FORM DEF 14A

Company

IGC Pharma, Inc.

Filed

July 26, 2023

Period of Report

August 18, 2023

Accession Number

0001185185-23-000759

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →